Atai life sciences to participate in upcoming september investor conferences

Berlin, sept. 03, 2021 (globe newswire) -- atai life sciences n.v. (nasdaq: atai) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that it will participate in in the following upcoming investor conferences in september:
ATAI Ratings Summary
ATAI Quant Ranking